Uflex Ltd

Price story Before the numbers, the tape. A stock price moves through four repeating seasons: a flat base (stage 1), an advance (2), a top (3), a decline (4). Where the price sits in that cycle frames everything below.

Uflex Ltd trades at ₹471, in a downtrend and 43 weeks into that stage. That is +2.3% against its own 200-day average. It sits at 56% of a 52-week range of ₹360 to ₹558. On relative strength it has been ahead of the NIFTY 500 on a trailing-13-week view for 4 straight weeks.

Today the stock is in a downtrend — week 43 of stage 4, confirmed. At ₹471 it trades +2.3% versus its 200-day average and sits at 56% of its 52-week range (₹360–₹558).

Against the market, two honest reads. Cumulative: over the last 10.4 years the stock moved +207% while the NIFTY 500 moved +276% — behind the index over the full window. Recent form: on a trailing-13-week view the stock has been ahead for 4 straight weeks — the ribbon below is that same metric, week by week.

What would end the trend, mechanically: two Friday closes in a row below the 200-day line. That is the exit rule — no debates.

Valuation P/E is the price of ₹1 of annual profit: how many rupees the market pays for each rupee the company earns in a year.

Uflex Ltd trades at 10.3× P/E, at the pricey end of its own range (77th percentile). Its long-run median P/E is 5.7×, measured across 10.4 years of weekly readings. This places the multiple against the stock’s own record, and says nothing about what the business is worth.

Today's P/E of 10.3× is at the pricey end of its own range (77th percentile), against a long-run median of 5.7× measured over 10.4 years of weekly readings. This is a comparison against the stock's own history — not a claim about what it is worth.

Why the multiple sits where it does: over the past year annual EPS moved +122.8% against a −19.2% price move — earnings outran the price, pushing the multiple DOWN its own range.

The price move, decomposed: over 5y, of the −2.8%/yr price move, ~−17.3%/yr came from earnings growth and ~+14.5 pp from the multiple (expanding); over 10y, of the +6.8%/yr price move, ~+0.3%/yr came from earnings growth and ~+6.5 pp from the multiple (expanding). The split is the honest approximate (price return minus earnings growth); it makes the rally itself visible instead of hiding it behind the percentile.

Put together: the multiple is full against its own past, so the story rests on the earnings line underneath it, not the multiple.

Stage: No read Every business sits somewhere on a fundamental arc, and this page names the spot before anything else. The last twelve quarters of revenue, profit and EPS growth — plus the return the business earns on its capital — are read as curves: Deteriorating (the curves are falling), Turning around (a trough has just formed and the last few quarters lift off it), Improving (the climb off the trough is sustained), Consistent (steadily positive with healthy returns), Topping out (still high but decelerating from the peak). When the curves genuinely disagree the read is Mixed; too little history is No read. CAGR (compound annual growth rate) is the smooth yearly pace that turns the starting value into the latest one — the fairest way to compare growth across different time spans. Read the columns together: if the 1-year number towers over the 10-year, recent growth is running hotter than the long-run trend. A dash means that window is not held, or the base year was a loss (where a growth rate is not meaningful).

Uflex Ltd reads as no read on its fundamental arc. Under eight usable quarters on the growth trio — not enough history for an honest trajectory read. The read is built from 12 quarters across 2 curves, on partial evidence.

Why it matters: with too little history, an honest page says so instead of guessing a trajectory.

Fewer than eight usable quarters on the growth curves — this page will not guess a trajectory from a stub of history.

4-Factor Sector Score

47.8/100 — rank 3 of 5 in Packaging - BOPP · 84% evidence confidence

Uflex Ltd scores 47.8 out of 100 against the 5 companies it is compared with in Packaging - BOPP, ranking 3. Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.

The four contributions add to the total exactly: 20.5 + 8.9 + 15 + 3.4 = 47.8. This is the SAME number shown on the sector comparison — it is computed once, for the whole peer set, and read here.

What would change it: The read weakens if profit growth turns negative or margin improvement reverses while sector-relative strength deteriorates.

Revenue Revenue is the top line: everything the company billed its customers in the period.

Uflex Ltd reported ₹4,056 Cr of revenue in the Mar 26 quarter, +6.3% year on year. Over 10 years it has compounded at 9.2% a year. The last full year, FY26, came in at ₹15,401 Cr. The last four reported quarters add to ₹15,401 Cr.

FY26 revenue came in at ₹15,401 Cr (+2.4% on the year), capping 10 years at 9.2% compound. The latest quarter (Mar 26) printed ₹4,056 Cr, +6.3% year on year.

Pace check: the last four quarters averaged +2.5% growth against the decade's 9.2% — the current year is running slower than its own long-run rate.

Acceleration check: trailing-twelve-month revenue grew +2.4% over the last 4 quarters against +7.4%/yr over the last 8 — rolling over.

Operating margin Operating margin is what is left of every ₹100 of sales after running the business, before interest and tax. It is the cleanest read on pricing power and cost control.

Uflex Ltd's operating margin is 14.0% in the Mar 26 quarter, +3.0 percentage points against the same quarter a year ago. Across 13 fiscal years the operating margin has ranged 10.0% to 20.0%. The current quarter sits inside that band.

The latest quarter's operating margin is 14.0%, +3.0 pp against the same quarter a year ago. Across 13 fiscal years the operating margin has ranged 10.0%–20.0%.

Why the margin moved: operating margin went +3.7 pp year on year while gross margin went +4.2 pp — the gain came mostly from the gross line: input costs and pricing.

Net profit Net profit is what survives every cost, interest and tax — the number EPS, dividends and book value all grow from.

Uflex Ltd earned ₹196 Cr of net profit in the Mar 26 quarter, +16.0% year on year. Full-year FY26 profit was ₹317 Cr. The 10-year compound rate is 0.0%. That is 4.8% of the quarter's revenue. The same quarter a year earlier earned ₹169 Cr. 5 of the last 12 reported quarters were loss-making.

Mar 26 profit was ₹196 Cr, +16.0% year on year. On the full year, FY26 printed ₹317 Cr (+123.2%), and the 10-year compound rate is 0.0%.

Cash flow — the router The P&L says what was earned; the cash-flow statement says what actually arrived. Operating cash flow (CFO) against profit is the cleanest lie detector in the accounts.

Over the last 3 fiscal years 373% of Uflex Ltd's reported profit arrived as operating cash — the cash follows the profit. In FY26 that was ₹992 Cr of operating cash against ₹317 Cr of profit. After ₹3,282 Cr of capital spending, ₹−2,290 Cr was left as free cash.

FY26: operating cash of ₹992 Cr against reported profit of ₹317 Cr, leaving free cash of ₹−2,290 Cr after ₹3,282 Cr of capital spending. Across the last 3 fiscal years the conversion rate is 373% of profit.

Cash-flow readings here are annual — that is the resolution our series carries, so this section moves once a year.

Why conversion sits at 373%: the cash cycle held roughly steady between FY21 and FY26 — so conversion tracks profitability rather than the cycle.

Router verdict: the bigger cash user is investment — capital spending ran 2.7× depreciation over three years, so the next section's job is to check what that build-out is buying.

Where the cash goes Working capital is the cash tied up between paying suppliers and getting paid: debtor days (customers owe), inventory days (stock waits), and the cash conversion cycle (the whole loop, in days of sales).

Uflex Ltd's cash conversion cycle runs 89 days in FY26, up from 83 days in FY21. Capital spending ran ₹5,844 Cr over the last 3 years. At FY26 sales of ₹15,401 Cr each day of that cycle holds about ₹42.2 Cr, so roughly ₹3,755 Cr sits inside the business at any moment.

FY26: debtors at 92 days, inventory at 97 days — roughly 3.2 months of stock waiting to sell; that is where the cash sits while it waits — for a full cycle of 89 days, looser than FY21's 83.

The full loop: cash goes out to suppliers and production on day 0; stock waits 97 days to sell; customers pay about 92 days after that; and suppliers themselves are paid at 99 days — netting out to the 89-day cycle.

In money terms: at FY26 sales of ₹15,401 Cr, each day of the cycle holds about ₹42.2 Cr — so the 89-day loop keeps roughly ₹3,755 Cr sitting inside the business at any moment.

On the investment side: capital spending of ₹5,844 Cr over the last 3 fiscal years against ₹2,137 Cr of depreciation — the company is building well ahead of wear-and-tear. Capital work-in-progress stands at ₹2,176 Cr (FY26) — capacity paid for but not yet earning.

The synthesis: the cash is going into capacity, not disappearing into the cycle — the question becomes whether the new capacity earns.

Return on capital Return on capital employed (ROCE) is the profit the whole business earns on all the money in it — equity and debt together. It is the single best test of whether growth creates value or just size.

Uflex Ltd earns a ROCE of 7% in FY26. That is up from a trough of 6% in FY24. Return on invested capital clears the cost of that capital by −6.7 percentage points, so growth here is not yet paying for the capital it uses. The wiring behind it is 2.1% net margin on 0.69× asset turns.

FY26 ROCE is 7%, recovered from a FY24 trough of 6% — the full ladder below shows the fall and the climb, undoctored.

🚨 Why the return is what it is — the wiring (FY26): 2.1% net margin × 0.69× asset turns × 2.73× balance-sheet leverage ≈ 4.0% on equity. Margin does its share; leverage is a meaningful part of the equation.

The capstone test — ROIC − WACC: 5.3% − 12.0% = a −6.7 pp spread. The 12.0% is a standing assumption for the cost of capital in India, not a per-stock estimate — read the sign and the size of the spread, not the decimals. Negative — growth at these returns destroys value until the returns recover.

Debt Debt-to-equity says how much of the business is funded by borrowings. Low is the safe corner; the trend matters as much as the level.

Uflex Ltd carries total debt of ₹10,152 Cr against shareholder equity of ₹8,122 Cr as of Mar 26, a debt-to-equity of 1.25. On the annual view that ratio went from 0.72 in FY22 to 1.25 in FY26. Read the returns elsewhere on this page with that leverage in mind.

Mar 26: total debt of ₹10,152 Cr against shareholder equity of ₹8,122 Cr — a debt-to-equity of 1.25. On the annual view, debt-to-equity went from 0.72 (FY22) to 1.25 (FY26). Read the returns on this page with that leverage in mind.

Ownership Who owns the stock, quarter by quarter: promoters (the controlling owners), foreign and domestic institutions, and the public. Steady accumulation by people close to the numbers is a signal; a quiet register is also an answer.

Foreign institutions added 2.0 points of Uflex Ltd over 8 quarters, the biggest move on the register. That takes foreign institutions to 10.0% of the company. Domestic institutions moved −0.1 points over the same window, to 0.6%. The register is read on the four disclosed classes only; nothing is inferred between filings.

The register over the last two years — Foreign institutions: +2.0 points over 8 quarters to 10.0%; Domestic institutions: −0.1 points over 8 quarters to 0.6%; Promoters: +0.0 points over 8 quarters to 44.6%.

Why the register moved: foreign institutions drove it (+2.0 points) — steady accumulation by institutions reading the same numbers this page reads.

Safety line The Z-score estimates how far a company sits from balance-sheet distress — above roughly 3 is safe, below roughly 1.8 is the danger zone. It was built for manufacturers, so it is not applied to banks and lenders.

Uflex Ltd: the Z-score is not available for this stock, so we say so rather than invent one. It is a distance-to-distress estimate from the balance sheet, not a forecast of failure. The debt, cash-flow and return sections above carry the balance-sheet evidence this page does hold, and each of them states its own reporting date.

The safety line in one sentence: the Z-score is not available for this stock, so we say so rather than invent one.

Frequently asked questions